FIELD: medicine.
SUBSTANCE: method involves measuring end diastolic size EDS and end systolic size ESS of the left ventricle. Conditionally constant value of these factors are to be determined from formulas: EDS(MEDS)=11.4-lnTV6, where TV6 is the 6 min test value. Difference between real EDS and ESS values and their conditionally constant values M is to be found. The value of M is compared to standard deviations for EDS - 0.52(σR1) and ESS - 0.45(σR2) to establish favorable functional state in EDS M±(σR2), ESS M±(σR1) cases; disharmonic functional state in EDS from M-1σR2 to M-2σR2, ESS M±1σR1 or M+2σR1; unfavorable functional state in EDS from M-2.1σR2 to M-3σR2 and more, ESS M±1σR1 or from M+1σR1 to M+2σR1 and more; unfavorable worsening functional state in EDS from M+1.1σR2 to M+2σR2 and more, ESS M±1σR1 or M±2σR1; extremely unfavorable functional state in EDS from M+2.1σR2 to M+3σR2 and more, ESS M±1σR1 or M±1.1σR1 to M±2σR1 and more.
EFFECT: high accuracy and reliability of diagnosis.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING THE SEVERITY OF CHRONIC CARDIAC FAILURE | 2004 |
|
RU2266039C1 |
METHOD FOR EVALUATING INITIAL STAGES OF HEART FAILURE SEVERITY DEGREE | 2002 |
|
RU2223030C2 |
METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
METHOD OF DIFFERENTIAL PRESCRIPTION OF β-ADRENORECEPTOR BLOCKING AGENTS IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2010 |
|
RU2454998C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF CHRONIC CARDIAC FAILURE IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2545899C1 |
METHOD TO ASSESS CHANGES IN SPEED OF PULSE WAVE PROPAGATION AS MARKER OF UNFAVOURABLE PROGNOSIS IN PATIENTS WITH CHRONIC CARDIAC FAILURE OF ISCHEMIC AETIOLOGY | 2009 |
|
RU2409312C1 |
METHOD FOR PREDICTING THE PROGRESSION OF CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER AFTER ANTHRACYCLINE CHEMOTHERAPY | 2022 |
|
RU2790788C1 |
METHOD FOR PERSONALIZED SELECTION OF PATIENTS WITH ANTHRACYCLINE-INDUCED CARDIOMYOPATHY AFTER POLYCHEMOTHERAPY OF BREAST CANCER FOR EFFECTIVE TREATMENT WITH CARVEDILOL | 2021 |
|
RU2778612C1 |
METHOD FOR REHABILITATION OF ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASES ACCOMPANIED BY CHRONIC HEART INSUFFICIENCY FOLLOWING MYOCARDIAL INFARCTION | 2014 |
|
RU2554756C1 |
METHOD FOR DETERMINING THE SEVERITY DEGREE OF CHRONIC HEART FAILURE IN PATIENTS WITH CARDIOVASCULAR DISEASES | 1999 |
|
RU2186519C2 |
Authors
Dates
2005-11-27—Published
2004-03-25—Filed